Company Filing History:
Years Active: 2013
Title: Qui Liu: Innovator in Ischemia Treatment
Introduction
Qui Liu is a notable inventor based in Houston, Texas, recognized for his contributions to medical science, particularly in the treatment of ischemia. His innovative work focuses on the use of mesodermal-like cell populations to address tissue ischemia in mammals.
Latest Patents
Qui Liu holds a patent for "Mesodermal-like cell population for treating ischemia in mammals." This patent describes compositions containing an effective amount of mesodermal-like multipotent mammalian mononuclear cells that express both CD34 and M-cadherin cell surface markers. These compositions are utilized for preventing, treating, or reducing the severity of tissue ischemia or ischemia-associated disorders in mammals. The patent outlines methods for repopulating an in vivo site with new myocytes and vascularizing ischemic or adjacent tissue. Additionally, it discusses the detection of CD34/M-cadherin mesodermal-like precursor cells in mammalian tissue samples to diagnose the need for transplantation of autologous cells to ischemic sites.
Career Highlights
Qui Liu is affiliated with the University of Texas System, where he continues to advance his research and innovations in the field of regenerative medicine. His work has significant implications for improving treatment options for patients suffering from ischemic conditions.
Collaborations
Some of Qui Liu's notable coworkers include Pierre Zoldhelyi and James T Willerson, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Qui Liu's innovative approach to treating ischemia through the use of mesodermal-like cells represents a significant advancement in medical science. His contributions are paving the way for new therapeutic strategies that could greatly benefit patients in need.